Home
>
National Drug Code (NDC)
>
Nalbuphine Hydrochloride
Nalbuphine Hydrochloride - 0409-1465-61 - (NALBUPHINE HYDROCHLORIDE)
Drug Information of Nalbuphine Hydrochloride
| Product NDC: | 0409-1465 |
| Proprietary Name: | Nalbuphine Hydrochloride |
| Non Proprietary Name: | NALBUPHINE HYDROCHLORIDE |
| Active Ingredient(s): | 20 mg/mL & nbsp; NALBUPHINE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nalbuphine Hydrochloride
| Product NDC: | 0409-1465 |
| Labeler Name: | Hospira, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070916 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110822 |
Package Information of Nalbuphine Hydrochloride
| Package NDC: | 0409-1465-61 |
| Package Description: | 10 AMPULE in 1 CARTON (0409-1465-61) > 1 mL in 1 AMPULE |
NDC Information of Nalbuphine Hydrochloride
| NDC Code | 0409-1465-61 |
| Proprietary Name | Nalbuphine Hydrochloride |
| Package Description | 10 AMPULE in 1 CARTON (0409-1465-61) > 1 mL in 1 AMPULE |
| Product NDC | 0409-1465 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NALBUPHINE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20110822 |
| Marketing Category Name | ANDA |
| Labeler Name | Hospira, Inc. |
| Substance Name | NALBUPHINE HYDROCHLORIDE |
| Strength Number | 20 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] |
